Cencora Inc.

COR | NYSE

Price Alert Chart Builder DCF Calculator

$308.78

-$0.63 (-0.20%)

At close: Sep 18, 2026, 4:00 PM ET

$307.01

-$1.77 (-0.57%)

Pre-market: Sep 21, 2026, 7:17 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

-0.20%

(1D)

Rating

Updated: Aug 29, 2026

49.2

Fundamentals Average

Market Sentiment Bullish

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $60.08B

1D Range

304.45 311.81

52W Range

244.82 377.54

Valuation (TTM)

PE 22.94

PB 19.69

EV/EBITDA 13.44

Valuation (NTM)

Forward PE 15.54

Forward PEG 2.11

Price Target $358.14

Cash Flow

FCF Yield 4.7%

SBC Adj. FCF Yield 4.4%

SBC Impact -6.7%

Margins

Gross Margin 3.7%

Operating Margin 1.3%

FCF Margin 0.8%

Growth (CAGR)

Revenue 3Y | 5Y 9.4% | 10.3%

Dil EPS 3Y | 5Y 17.9% | 11.1%

FCF 3Y | 5Y 0.2% | 1.8%

Returns

ROA 3.1%

ROE 106.4%

ROIC 12.8%

Financial Health

Net Debt

$8.91B

Current Ratio 0.93

Interest Coverage 8.71

Dividends

Div Yield 0.78%

Payout Ratio 17.8%

FCF Payout Ratio 25.4%

All Key Statistics

Loading financial charts...

Profile

Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healt...

Sector Healthcare

Industry Medical - Distribution

Employees 49,000

IPO Date Apr 3, 1995

Website www.cencora.com

Fiscal Year October - September

Full Company Profile

Latest News

6 hours ago · marketbeat.com

Cencora Highlights Specialty Growth, MSO Expansion and Walgreens Ties at Conference

Cencora NYSE: COR executives highlighted the company's specialty pharmaceutical positioning, medical specialty organization strategy and capital-allocation priorities during an investor conference discussion, while reaffirming the durability of its relationship with Walgreens.

3 days ago · zacks.com

Here's Why Cencora (COR) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

5 days ago · seekingalpha.com

Cencora, Inc. (COR) Presents at 2026 Global Healthcare Conference Transcript

6 days ago · seekingalpha.com

Cencora, Inc. (COR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

11 days ago · zacks.com

Here's Why Cencora (COR) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.